Focus Area
PHARMeMED Ā· The industry in context
Discover whatās next in pharma, biotech and medtech.
Important news, emerging therapies and professional opportunities, all in one place.
Biopharma Markets
Market data may be delayed.
Lead News
The latest developments
Latest News
Meet Ā· Learn Ā· Connect
Latest Events
Research & perspectives
Featured Resources
Explore the intelligence behind the headlines
Follow the companies, drugs and diseases connected to industry developments.
Your weekly briefing
Subscribe to the Newsletter
Your weekly briefing, free to subscribe. Professional interests and preferences are optional.
Subscribe to the NewsletterProfessional opportunities
Subscribe
Choose job, consulting or partnership alerts, with optional private professional preferences.
SubscribeAbout PHARMeMED
Connected intelligence for pharmaceutical and life sciences professionals.
PHARMeMED is a pharmaceutical and life sciences publishing and intelligence platform. It brings industry news together with connected information on companies, drugs, diseases, events and publications, helping professionals move from a development to the context around it.
01
Who PHARMeMED serves
PHARMeMED is designed for professionals working across pharmaceutical, biotechnology, medical technology and the wider life sciences ecosystem who need relevant developments and structured context in one place.
02
Connected intelligence
News is more useful when its context is visible. PHARMeMED connects reporting with company profiles, medicines, disease landscapes, industry events and professional publications.
03
Editorial mission
Our editorial mission is to make a complex industry easier to understand without reducing it to headlines or disconnected databases. We select developments for professional relevance and present them with clarity and restraint.
04
Editorial and technology approach
PHARMeMED uses editorially directed, AI-assisted workflows to support research, organisation and connections across the platform. Published material is human-reviewed. Technology supports the work; editorial judgement remains accountable for what appears on PHARMeMED.
05
Community context
PHARMeMED has grown in relationship with a LinkedIn community network of more than two million pharmaceutical and life sciences professionals. That community provides valuable context on the topics and professional needs that matter across the sector, while PHARMeMED maintains its own platform, editorial standards and direction.
06
Future direction and independence
PHARMeMED is developing as an independent industry publishing and intelligence platform. Editorial coverage is selected for relevance and value to readers. Commercial relationships and sponsored material should be clearly identified and should not determine editorial conclusions.
Weekly briefing
Subscribe to Newsletter
Weekly curation with no professional profile required.
Subscribe to NewsletterProfessional opportunities
Subscribe
Choose the newsletter, professional opportunities or both. Each choice is independent.
SubscribeContact PHARMeMED
How can we help?
Contact PHARMeMED about editorial coverage, events, publications, partnerships, promotion, hiring an expert, recruitment or technical support.
Company search
Companies
No companies match the current filters.
Company intelligence
Companies
No companies match this page yet.
Connected pharmaceutical intelligence
Focus Areas
No matching terms found.
Profile review request
Submit Correction
Suggest updates to an existing company profile. Changes are reviewed before publication.
Industry updates
News
No news articles match the current filters.
Professional chronology
Intelligence
No published Intelligence Updates match the current filters.
Industry calendar
Events
No events match the current filters.
Industry content library
Publications
Latest Publications
No publications match the current filters.
Drug Directory
Drugs
Drug Profiles are currently being added.
Explore approved medicines, pipeline candidates, mechanisms of action, therapeutic areas and company relationships.
Disease Directory
Explore disease intelligence
Connect diseases with the drugs, companies, news, publications and events shaping pharmaceutical development.
No reviewed public diseases match the current filters.
PHARMeMED for professionals
Subscribe to PHARMeMED
Choose the weekly briefing, professional opportunities or both. Select only the communications you want, then verify your email.
Free to subscribe. Detailed professional information stays private.
PHARMeMED for professionals
Site policy
Privacy Policy
Site policy
Terms of Use
Site policy
Editorial & Information Disclaimer
Optional model cancellation form
Using this form is optional. Read the Terms of Use for consumer cancellation rights.
Submit a Listing
Choose a publishing pathway below. Each submission follows the review and payment process, where applicable, shown in its dedicated form.
Add or Claim a Company
Suggest a new company, claim an existing profile or share a factual update for editorial review.
Start company contributionAdd Event
Share a pharma, biotech, clinical research, regulatory or life sciences event.
Start event submissionAdd Publication
Submit a report, white paper, guide, case study or industry publication.
Start publication submissionAdd or Correct a Drug
Submit a new drug profile suggestion or correction for editorial review.
Start drug submissionDatabase admin
Admin Panel
Site Settings
Promo Codes
Listing Submission Queue
Subscribers
0 subscribers shown
Content Taxonomy
Taxonomy Groups
Terms
Aliases
Publication Categories
Publication Types
Therapeutic Areas
Editorial Workspace
Newsroom
Review AI-prepared story options, open the article workspace, and publish finished PHARMeMED news quickly.
AI Newsroom v1
Editorial Event Queue
One underlying event retains all source evidence and produces one canonical brief, article and image workflow.
Discovery Intelligence
Discovery Sources
Priority sources for future story discovery. No scraping is active yet.
AI Newsroom Editorial Queue
Ready-to-review story queue
Review ranked story options, open or generate the PHARMeMED article, check image status, then publish.
Source health tracked Ā· 08:00, 12:30, 17:00 London windows
Control Panel
Articles
Events
Event Intake Review
Review imported TradePub webinars below, or paste a public event URL to extract a draft. Publishing always requires your approval.
Review Imported Events
Catalogue presence reflects the last successful import, not whether a webinar is playable. Catalogue dates are not Event dates.
AI / Manual Event Intake
Events created from manually supplied URLs or supporting information.
Drugs
Quick Add Drug
Create a structured draft quickly, then refine aliases, references, company roles and taxonomy links in the full editor below.
Drug Import Assistant
Paste trusted source URLs or source text, review the extracted draft, then approve it into the Drug Directory as an admin-only draft drug.
Drug Submissions
Public drug suggestions and corrections awaiting editorial review. These records do not publish drug data.
Library
Publications
Review imported resources or publish an editorial publication.
TradePub Feed Health Private discovery feed
Review Publications
Relevant unpublished records needing an editorial decision, regardless of import date. Nothing is published automatically.
Feed Review Queue
0 selected
Publication Opportunity Intelligence Private editorial ranking
Publication editorial workspace
Discover, preview, create a draft, approve and publish without leaving Publications.
Private Preview
Publication Preview
Uses the same publication presentation components as the published page. It is not public or indexed.
Editorial Calibration Workspace Private human review
Recommendation quality review
Decisions remain private and survive recalculation. Nothing here publishes or distributes a resource.
Import Publication
Paste a public TradePub URL and click Extract Draft.